Yu Wei, Hu Shiyun, Xu Xiaoling, Shao Jianlin, Yan Jing, Ding Fang
Zhejiang Provincial Center for Cardiovascular Disease Control and Prevention, Zhejiang Hospital, Hangzhou, 310013, China.
BMC Cardiovasc Disord. 2025 Apr 12;25(1):281. doi: 10.1186/s12872-025-04732-6.
The O-GlcNAc transferase (OGT) levels are closely related to the O-GlcNAcylation of proteins and are also associated with cardiovascular disease. This study explored the association between OGT activity and major adverse cardiovascular events (MACEs) in patients with high cardiovascular disease risk. This post hoc study included patients from the China PEACE-MPP study in Yi Wu, Zhejiang Province, between 2014 and 2015.
The patients were divided into the low and high OGT activity groups according to the median serum OGT value. The outcome was the occurrence of MACEs (cardiovascular death, non-fatal acute myocardial infarction, and non-fatal ischemic stroke).
Finally, 1947 participants (973 and 974 with low and high OGT activity, respectively) were included. The mean follow-up was 5.56 ± 1.01 years. The participants in the low OGT activity group had a significantly higher occurrence rate of MACEs compared with the high OGT activity group (100 [10.4%] vs. 74 [7.6%], P = 0.032). The Kaplan-Meier analysis showed that the event-free survival rate in the low OGT activity group was significantly lower than in the high OGT activity group (P = 0.036). Multivariable Cox proportional hazards regression analysis showed that after adjustment for age, drinking, hyperglycemia, history of hypertension, and history of cardiovascular and cerebrovascular disease, a high OGT activity was independently associated with a lower risk of MACEs (HR = 0.738, 95%CI: 0.547-0.997, P = 0.048).
A low OGT activity was independently associated with an increased risk of MACE among patients with a high risk of cardiovascular disease.
Not applicable.
O-连接的N-乙酰葡糖胺转移酶(OGT)水平与蛋白质的O-连接的N-乙酰葡糖胺化密切相关,并且也与心血管疾病有关。本研究探讨了心血管疾病高风险患者中OGT活性与主要不良心血管事件(MACE)之间的关联。这项事后分析研究纳入了2014年至2015年间来自浙江省义乌市中国PEACE-MPP研究的患者。
根据血清OGT值中位数将患者分为OGT活性低和高两组。观察终点为MACE的发生情况(心血管死亡、非致死性急性心肌梗死和非致死性缺血性卒中)。
最终纳入1947名参与者(OGT活性低和高的分别有973名和974名)。平均随访时间为5.56±1.01年。与OGT活性高的组相比,OGT活性低的组中MACE的发生率显著更高(100例[10.4%]对74例[7.6%],P=0.032)。Kaplan-Meier分析显示,OGT活性低的组中无事件生存率显著低于OGT活性高的组(P=0.036)。多变量Cox比例风险回归分析显示,在调整年龄、饮酒、高血糖、高血压病史以及心血管和脑血管疾病史后,高OGT活性与较低的MACE风险独立相关(HR=0.738,95%CI:0.547-0.997,P=0.048)。
在心血管疾病高风险患者中,低OGT活性与MACE风险增加独立相关。
不适用。